Login / Signup

Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir-potential influence of censored observation. Authors' reply.

Chien-Hung ChenCheng-Yuan Peng
Published in: Alimentary pharmacology & therapeutics (2023)
Keyphrases
  • hepatitis b virus
  • risk factors
  • antiretroviral therapy
  • human health
  • risk assessment